ライフサイエンスコーパス: GABA

1 GABA is a key regulator of adult-born dentate granule ce

2 GABA release from ipRGCs dampened the sensitivity of bot

3 GABA(A) receptors (GABA(A)Rs) are profoundly important f

4 GABA(A) receptors are composed of five subunits arranged

5 GABA(B1) recognizes orthosteric ligands(7,8), while GABA

6 g in the pore of the alpha(2)beta(3)gamma(2) GABA receptor type A receptor at the so-called T6' ring,

7 steroid-binding sites in the alpha(1)beta(3) GABA(A) receptor (GABA(A)R) contributes to neurosteroid

8 eurons in the GAD67-GFP line (GABA+GFP ~45%, GABA+GFP + PV ~15%, and GABA+PV ~10%).

9 linked mutation in Gabrg2, a gene encoding a GABA(A) receptor subunit.

10 n, periventricular endothelial cells house a GABA signaling pathway with direct implications for psyc

11 Baclofen is a GABA(B) agonist prescribed as a treatment for spasticity

12 ats by locally concentrating and releasing a GABA(A) receptor agonist from ultrasound-controlled carr

13 marily mediated by chloride-permeable Type A GABA receptors.

14 could play a regulatory role here, we use a GABA 'sniffer' patch in acute hippocampal slices of the

15 ding for the gamma-aminobutyric acid type A (GABA(A) ) receptor subunit beta2.

16 lar to the widely used GABA receptor type A (GABA(A)) antagonist picrotoxinin, TETS has been proposed

17 ll metabotropic receptors for acetylcholine, GABA, and glutamate, completing a map of this communicat

18 Gamma-Aminobutyric acid (GABA) accumulates in plants following exposure to heavy

19 Gamma-aminobutyric acid (GABA) and glutamate are the most abundant amino acid neu

20 and quantified both gamma-aminobutyric acid (GABA) and glutamate release and phospho-cFos expression

21 Glutamate (GLU) and gamma-aminobutyric acid (GABA) are the major excitatory (E) and inhibitory (I) ne

22 ry neurotransmitter gamma-aminobutyric acid (GABA) at non-image-forming brain targets.

23 luding amido-diols, gamma-aminobutyric acid (GABA) derivatives, and heterocycles.

24 cheese enriched in gamma-aminobutyric acid (GABA) influences daytime ambulatory blood pressure (BP)

25 gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter within th

26 nia (excitatory and gamma-aminobutyric acid (GABA) mediated) and bipolar disorder (excitatory).

27 itical actor of the gamma-aminobutyric acid (GABA) metabolism as it catalyses the decarboxylation of

28 The gamma aminobutyric acid (GABA) neurotransmission system has been implicated in au

29 enhancement of the gamma-aminobutyric acid (GABA) neurotransmitter system in the prelimbic cortex (P

30 GABA(B) receptor by gamma-aminobutyric acid (GABA) results in prolonged inhibition of neurotransmissi

31 ificant increase in gamma-aminobutyric acid (GABA) transmission compared with rats with low addiction

32 -subunit-containing gamma-aminobutyric acid (GABA)(A) receptors (alpha5-GABARs).

33 ity of glutamate to gamma-aminobutyric acid (GABA), DA, and glutamate neurons within three sub-region

34 bumin subset of SNr gamma-aminobutyric acid (GABA)-releasing (GABAergic) neurons was preferentially a

35 y neurotransmitter, gamma-aminobutyric acid (GABA).

36 tonic inhibition by gamma-aminobutyric acid (GABA).

37 mical staining for gamma amino butyric acid (GABA) and parvalbumin (PV) to characterize GABAergic cel

38 roinflammation, microglial/glial activation, GABA signaling, and intestinal dysbiosis compared with o

39 ls that disease-inducing variants can affect GABA(A)R structure, and consequently subunit assembly an

40 Chemogenetic inhibition of all GABA interneurons (Gad1+), as well as Sst+ and Pvalb+ su

41 we report the characterization of an alpha1-GABA(A)R variant that results in severe epilepsy.

42 sion by systemic administration of an alpha5-GABA(A) receptor negative allosteric modulator, L-655,70

43 evidence indicates lower hippocampal alpha5-GABA(A)Rs protein and mRNA levels in schizophrenia.

44 However, it is unclear if alpha5-GABA(A)Rs are altered in vivo or related to symptoms.

45 alpha5 subtype of the GABA receptor (alpha5-GABA(A)Rs) leads to behavioral phenotypes associated wit

46 ine neurons and the expression of the alpha6 GABA(A) receptor subunit at the mossy fiber-granule cell

47 e synaptic response is influenced by ambient GABA and that changes in ambient concentrations of the t

48 line (GABA+GFP ~45%, GABA+GFP + PV ~15%, and GABA+PV ~10%).

49 ts had lower expression of GABA(Aalpha1) and GABA(Aalpha2) subunits in RVLM but only GABA(Aalpha2) wa

50 arrangement of glutamate, acetylcholine, and GABA receptors along the dendrite that matched the previ

51 This differential transmission of ACh and GABA based on the postsynaptic target neuron is reflecte

52 A(B) receptor has two subunits, GABA(B1) and GABA(B2), that are structurally homologous but perform d

53 eous acquisitions of GABA concentrations and GABA(A) receptor densities can identify objective molecu

54 ome cases, for example Dopamine-PKA-CREB and GABA-PKC-CREB signaling pathways, the biotypes were oppo

55 iosensors detect relevant changes in GLU and GABA levels that are consistent with various behaviors.

56 tions in the neurotransmitters glutamate and GABA correlate with impulsive behaviour in several neuro

57 We measured glutamate and GABA levels using semi-LASER magnetic resonance spectros

58 ctroscopy (MRS) measures local glutamate and GABA noninvasively.

59 unctional changes in forebrain glutamate and GABA systems, recapitulating aspects of the consequences

60 vels of tryptophan and GABA-to-glutamate and GABA-to-glutamine ratio (FDR-p < 0.05).

61 re glutamate, glutamate+glutamine (Glx), and GABA levels in dorsal anterior cingulate cortex (ACC) an

62 rval intracortical inhibition(,) 2.5 ms) and GABA(B) (long-interval intracortical inhibition(,) 150 m

63 nociception could exist between oxytocin and GABA at RAIC.

64 ron emission tomography ([(18)F]FMZ-PET) and GABA concentrations by using proton magnetic resonance s

65 aining auditory-recipient matrix regions and GABA-rich modules that are innervated by somatosensory i

66 PRO), tryptophan (TRP), tyrosine, serine and GABA were quantified by gas-chromatography-mass spectrom

67 1/38 : 3, and lower levels of tryptophan and GABA-to-glutamate and GABA-to-glutamine ratio (FDR-p < 0

68 with other drug classes (mGluR5 antagonists, GABA-A and -B agonists).

69 trast, activating all ventral tegmental area GABA neurons resulted in a uniform decrease in respondin

70 global activation of ventral tegmental area GABA neurons, which will activate local inhibitory circu

71 gic neurons by blocking excessive astrocytic GABA could be an effective therapeutic strategy against

72 Blocking the astrocytic GABA synthesis recapitulates the therapeutic effect of o

73 ed by the loss-of-function of the astrocytic GABA transporter GAT-1 that does not necessarily derive

74 unappreciated reciprocal interaction between GABA and the endocannabinoid system in which GABA signal

75 Here, we show that blocking GABA transporters (GATs) in acute rat brain slices conta

76 Such phasic bursting by GABA neurons also occurred in WT mice in association wit

77 ostsynaptic currents (EPSCs) are followed by GABA(A) receptor-independent outward currents, reflectin

78 ry synaptic inputs are strongly inhibited by GABA(B)Rs, while optogenetic activation of the interneur

79 translocation were considerably inhibited by GABA.

80 ory transmission in the brain is mediated by GABA acting on GABA(A) receptors (GABA(A)Rs), which prov

81 tic modes of signal transduction mediated by GABA(B) dimers, and have important implications for rati

82 These CeA GABA neurons express dynorphin, somatostatin, and/or cor

83 ons in the extracellular GABA concentration [GABA] could play a regulatory role here, we use a GABA '

84 Concurrently GABA caused further increases in catalase and superoxide

85 he central nervous system, alpha5-containing GABA(A) receptors in airway smooth muscles are considere

86 ch has focused on studying alpha5-containing GABA(A) receptors.

87 rent views suggest gamma2 subunit-containing GABA(A) receptors mediate phasic IPSCs while extrasynapt

88 tely selective for alpha5-subunit-containing GABA(A) receptors, the derivative SH53d-acid shows super

89 e ventral tegmental area (VTA) has dopamine, GABA, and glutamate neurons, which have been implicated

90 proach identified the effect of a test drug (GABA-reuptake inhibitor, tiagabine) on neuronal function

91 transporter, KCC2, suggesting less effective GABA-mediated inhibition compared to active rats.

92 d withdrawal.SIGNIFICANCE STATEMENT Elevated GABA signaling in the central nucleus of the amygdala (C

93 itive allosteric modulator diazepam enhanced GABA-A currents on dopaminergic axons and directly inhib

94 Here, we find that excessive GABA release from basket cells (BCs) attenuates the firi

95 TMS) measures of corticospinal excitability, GABA(A) (short-interval intracortical inhibition(,) 2.5

96 ty trigger widespread waves of extracellular GABA in hippocampal neuropil.

97 Elevations of extracellular GABA narrow the coincidence detection window for excitat

98 hat, by dynamically regulating extracellular GABA, brain network activity can optimise signal integra

99 st whether fluctuations in the extracellular GABA concentration [GABA] could play a regulatory role h

100 There were abnormally few GABA neurons in the hypothalamus in the mutant larvae, a

101 were elevated in Cd-exposed plants following GABA application.

102 ry lobe cluster were also immunoreactive for GABA and the GABA-synthesizing enzyme glutamic acid deca

103 ulbospinal non-C1 neurons immunoreactive for GABA(Aalpha1) but a higher percentage of bulbospinal C1

104 of bulbospinal C1 neurons immunoreactive for GABA(Aalpha1) in sedentary animals.

105 inal C1 or non-C1 neurons immunoreactive for GABA(Aalpha2) .

106 H1s were identified by immunoreactivity for GABA and 95% of these cells had an r(d/s) < 4.

107 nges in the dendritic reversal potential for GABA.

108 and perforated-patch recordings to test for GABA-A receptors on the main dopaminergic neuron axons a

109 the decarboxylation of glutamic acid to form GABA.

110 receptors are organized hierarchically: from GABA(A)R super-complexes with a preferred inter-receptor

111 inhibitor, tiagabine) on neuronal function (GABA-ergic dynamics), opening the way for psychopharmaco

112 bolites and enzymes from the GABA-glutamate, GABA-putrescine, and the glyoxylate pathways significant

113 esthetic drugs that modulate the heteromeric GABA(A) receptor, it maintains a rich and multifaceted s

114 S measurements revealed significantly higher GABA/Water (GABA normalized by water signal) in the left

115 However, GABA(B) is unique in its function as an obligate heterod

116 sion between the MHb and its sole identified GABA input, the medial septum and nucleus of the diagona

117 RBCs from retinas deficient in GABA release also demonstrate dyad mis-arrangements but

118 ions of interest, we found no differences in GABA(A) receptor densities between ASD and TD groups.

119 or (MOR) gene, Oprm1, is highly expressed in GABA neurons, with ~50% of GABA neurons in the substanti

120 Learning induced a lasting increase in GABA release and this was responsible for driving the ch

121 re likely mediated by stimulation of MORs in GABA afferents from other brain regions than in VTA GABA

122 ions in area parameters could be observed in GABA-CB1-KO mice.

123 ynthesis-dependent long-lasting reduction in GABA release.

124 n OSN release probability and a reduction in GABA(B) receptor expression in the conditioned glomerulu

125 ing the signaling pathways causing increased GABA release in a mouse model of NF1 reverts deficits in

126 TUS increased GABA(A)-mediated short-interval intracortical inhibition

127 nputs to pyramidal cells whereas increasing [GABA] through GABA uptake blockade shortens it.

128 atory AMPA receptors (AMPARs) and inhibitory GABA(A) receptors.

129 mals, microglia depletion reduced inhibitory GABA(A) and excitatory glutamate receptor-mediated synap

130 ovel role for NO in strengthening inhibitory GABA(A) receptor-mediated transmission in molecular laye

131 d neurochemical motifs with distinct inputs: GABA-rich modules are innervated by somatosensory struct

132 tic effects being mediated by the ionotropic GABA type A receptors (GABA(A)Rs).

133 ositive and negative valence encoding in its GABA and glutamate neurons that influence both approach

134 Lesion of peri-LC GABA neurons blocked LH stimulation-induced eating, esta

135 otential interneurons in the GAD67-GFP line (GABA+GFP ~45%, GABA+GFP + PV ~15%, and GABA+PV ~10%).

136 ly biased toward synaptic contact with local GABA neurons.

137 d a frameshifting de novo variant in a major GABA(A)R gene, GABRA1 This truncated the alpha1 subunit

138 nce and elucidate the underlying mechanisms, GABA (0, 25 and 50 uM) was applied to Cd-treated maize p

139 neurons can be determined by plasma membrane GABA uptake transporters (GATs) located on astrocytes an

140 em to chemogenetically activate mesoaccumbal GABA projections in male rats during a novel cue-depende

141 Stimulation of the metabotropic GABA(B) receptor by gamma-aminobutyric acid (GABA) resul

142 25) Cell surface expression of mutant murine GABA(A)Rs is severely impaired compared with WT, due to

143 ated with CUD involved in neurotransmission (GABA, acetylcholine, serotonin, and dopamine) and drug a

144 er glutamate and inhibitory neurotransmitter GABA in regulating delay activity in rhesus monkeys perf

145 reuptake of the inhibitory neurotransmitter GABA is essential, and reuptake failure worsens human se

146 l switch of response to the neurotransmitter GABA, from excitatory depolarization to inhibitory hyper

147 om increased release of the neurotransmitter GABA.

148 highlight a potential avenue to develop new GABA(A)R psychopharmacology by targeting these receptor-

149 n of DA release augmented, and nigrostriatal GABA co-release attenuated.

150 n endogenous opioid-like peptide, normalized GABA transmission in HA rats.

151 erminal fragment of FMRP into BCs normalizes GABA release in the Fmr1-KO synapses.

152 nesfatin-1 hyperpolarizes dopamine, but not GABA, neurons of the VTA by inducing an outward potassiu

153 we summarize recent findings on these novel GABA(A)R transmembrane regulators and highlight a potent

154 ghly expressed in GABA neurons, with ~50% of GABA neurons in the substantia nigra pars reticulata (SN

155 s incorporating simultaneous acquisitions of GABA concentrations and GABA(A) receptor densities can i

156 Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents.

157 The blockade of GABA(A) receptors strongly improved the selectivity of t

158 ation alpha3beta2gamma1 conforms the bulk of GABA(A)Rs in oligodendrocytes from rat neonates.

159 hat exposure to micromolar concentrations of GABA can both activate the postsynaptic receptors genera

160 napses and regulates the synaptic content of GABA(A)Rs through the UNC-40-dependent intracellular sca

161 as been used to evaluate the distribution of GABA(A) receptors in the brain, and studies of modulatio

162 Furthermore, the effect of GABA on apoptosis is mediated by inputs from medial gang

163 of beta-carbolines as selective enhancers of GABA(A)Rs in OLs may help to study the role of GABAergic

164 not associated with changes in expression of GABA(A)R or of the chloride co-transporter KCC2, but rat

165 that sedentary rats had lower expression of GABA(Aalpha1) and GABA(Aalpha2) subunits in RVLM but onl

166 bits BMAL1-controlled rhythmic expression of GABA-A receptor gamma2 subunit, and dampening rhythmicit

167 ependent rats, this 5-HT-induced increase of GABA release was attenuated, suggesting blunted CeA 5-HT

168 The network influence of GABA transmission was analyzed using cell-attached recor

169 netic approach to determine if inhibition of GABA interneurons in the mPFC of male mice is sufficient

170 een believed to be mediated by inhibition of GABA interneurons in the VTA that subsequently leads to

171 drugs are thought to occur via inhibition of GABA interneurons.

172 We have previously shown that inhibition of GABA synthesis in the PeF produces panic-vulnerable rats

173 psychotic-naive patients had lower levels of GABA in dorsal ACC (p = .03), and the subgroup of patien

174 n/MADD-4, which controls the localization of GABA(A)Rs by positioning NLG-1/neuroligin at synapses an

175 A loss of GABA signaling is a prevailing hypothesis for the pathog

176 ed the S-SCAM overexpression-induced loss of GABA(A) receptors, supporting that GABAergic synapse los

177 The majority of GABA(A) receptors in the mammalian brain consist of two

178 lcohol as a positive allosteric modulator of GABA(A) receptors, a decrease in dopamine function, and

179 election of movements, impaired operation of GABA signaling within the striatum, and hyper-excitabili

180 ent positive allosteric modulators (PAMs) of GABA(A) receptors (GABA(A)Rs) with in vivo anesthetic, a

181 pothesized that function and pharmacology of GABA(A)Rs are determined by the channel pore-forming sub

182 BZDs are mediated by separate populations of GABA(A)Rs containing either alpha1, alpha2, alpha3, or a

183 molecular and pharmacological properties of GABA(A)Rs in OLs.

184 ficient per se, for efficient recruitment of GABA(A) receptors at GABAergic synapses in C. elegans Th

185 Both reduction of GABA release and synaptic inputs onto pyramidal cells er

186 changes that underlie long-term reduction of GABA release.

187 We identify the regulation of GABA availability by mitochondrial activity as a biologi

188 nit play a role in the dynamic regulation of GABA(A)R accumulation at inhibitory synapses, thereby re

189 ighlight the importance of the co-release of GABA and glutamate from immature glycinergic MNTB termin

190 ation that may signal through the release of GABA and/or dopamine.

191 To investigate the role of GABA in cadmium (Cd) tolerance and elucidate the underly

192 Yet, the role of GABA in the immune system has remained elusive.

193 vivo the properties, activities, and role of GABA neurons within the laterodorsal tegmental and subla

194 Here, we study the roles of GABA and insulin signaling in starvation-dependent modul

195 +)VGluT3(+)INTs) has prompted speculation of GABA/glutamate corelease from these cells for almost two

196 romotes the recruitment and strengthening of GABA(A) receptor synapses via Ca(2+)/calmodulin-dependen

197 Structures of GABA(A) receptors in complex with the anaesthetics pheno

198 vents in alpha4, beta, and gamma subunits of GABA(A)Rs govern their function and trafficking, phospho

199 be novel astroglial pathway for synthesis of GABA, which is subsequently released through plasmalemma

200 e of development, delaying the trajectory of GABA's polarity transition and altering early-life commu

201 Withdrawal of GABA(A) receptor-mediated inhibition of the RVLM increas

202 f the rat and document strong dependence of [GABA] on network activity.

203 n in the brain is mediated by GABA acting on GABA(A) receptors (GABA(A)Rs), which provides inhibitory

204 itory, or competitive antagonist activity on GABA(A)Rs.

205 hus, dynorphin has contrasting influences on GABA input to VP(GABA) and VP(vGluT2) neurons and these

206 ne were blocked by GluN2B-NMDAR knockdown on GABA (Gad1) interneurons, as well as subtypes expressing

207 ogether, these findings suggest that MORs on GABA neurons in the SNr play more important roles in opi

208 and GABA(Aalpha2) subunits in RVLM but only GABA(Aalpha2) was lower in the RVLM(RE) of sedentary rat

209 ic manipulation of mitochondrial activity or GABA signaling corrects the observed abnormalities.

210 (ir) neurons express vesicular glutamate or GABA transporters.

211 pressing the vesicular glutamate (vGLUT2) or GABA transporter (vGAT), then determined whether TH-ir n

212 Randomized Efficacy and Safety Trial of Oral GABA(A) alpha5 antagonist S44819 after Recent ischemic E

213 pNon-GABA, which likely included cholinergic, neurons were in

214 fect is mediated by the loss of postsynaptic GABA(A) receptors, gephyrin, and neuroligin 2 and does n

215 nd to all three sites, but do not potentiate GABA(A)R currents.

216 tagonist) or by (2) bicuculline (a preferent GABA(A) receptor blocker), suggesting a GABAergic activa

217 Presumed GABA (pGABA) neurons were identified by response to phot

218 Only within a narrow range does prolonging GABA(B) receptor activity promote channel opening and in

219 T) provides enhanced resolution to quantify GABA and Glu levels in the thalamus of CHR individuals.

220 tes in the alpha(1)beta(3) GABA(A) receptor (GABA(A)R) contributes to neurosteroid allosteric modulat

221 l environment age on their GABA(A) receptor (GABA(A)R) responses, elicited by muscimol.

222 ted by the ionotropic GABA type A receptors (GABA(A)Rs).

223 GABA(A) receptors (GABA(A)Rs) are profoundly important for controlling neur

224 eric modulators (PAMs) of GABA(A) receptors (GABA(A)Rs) with in vivo anesthetic, anxiolytic, and anti

225 ediated by GABA acting on GABA(A) receptors (GABA(A)Rs), which provides inhibitory balance to excitat

226 property associated with outward rectifying GABA(A) receptors.

227 LRRTM4 knockout could originate from reduced GABA receptor function.

228 specialized VIP(+) interneurons that release GABA strongly onto other inhibitory interneurons and ace

229 ing of glutamate causes GC spines to release GABA both synchronously and asynchronously onto MC dendr

230 dy, we analyzed modulation of the human rho1 GABA(A) receptor by several neurosteroids, individually

231 The study describes modulation of the rho1 GABA(A) receptor by neurosteroids.

232 The rho1 GABA(A) receptor is prominently expressed in the retina

233 Most pvBCs showed robust GABA(A)R-mediated self-innervation in both species, but

234 ression of specific markers for the rostral (GABA, GAD67, Lhx1, and Nkx2.2) and caudal (Gbx2, VGlut2,

235 s coping style and that expression of select GABA(A) receptor subunits may be one of the underlying m

236 rent state of the field of subtype-selective GABA(A)R modulators acting via the BZD binding site and

237 ogy of BZDs indicates that subtype-selective GABA(A)R modulators will have novel pharmacological prof

238 hanism, CeA inputs preferentially target SNL GABA neurons, and CeA->SNL and SNL dopamine neurons resp

239 In addition, activation of SNr GABA neurons attenuated heroin-primed, but not cue-induc

240 -seeking behavior, whereas inhibition of SNr GABA neurons produced optical intracranial self-stimulat

241 ity as well but also facilitates spontaneous GABA release and triggers an increase in the density of

242 Ambient striatal GABA tone on striatal projection neurons can be determin

243 elease is under tonic inhibition by striatal GABA.

244 Past work has shown that striatal GABA tonically inhibits dopamine release, but whether GA

245 ies have provided new dimensions in studying GABA(A)Rs due to several transmembrane proteins that int

246 The alpha5 subtype GABA-A receptor availability was indexed using [(11)C]Ro

247 2-6), the GABA(B) receptor has two subunits, GABA(B1) and GABA(B2), that are structurally homologous

248 o the activity-induced dispersal of synaptic GABA(A) receptors.

249 PI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma

250 is a significant effect modifier of thalamic GABA/Water's relationship with AQ and RAADS-R scores for

251 We found that GABA/Glu was significantly reduced in the right medial a

252 Altogether, these findings indicate that GABA/Glu abnormalities are present in the thalamus befor

253 learning and so there is a possibility that GABA agonist drugs, such as baclofen, could impair these

254 We show that GABA(B)-receptor and insulin-receptor play important rol

255 ons of transmitter lifetime, suggesting that GABA release recruits delta receptors proportionally to

256 The GABA response switch from excitatory to inhibitory is a

257 The GABA/Glu reduction was negatively correlated with genera

258 re heterodimerization for function(2-6), the GABA(B) receptor has two subunits, GABA(B1) and GABA(B2)

259 erential regulation of the TCA cycle and the GABA shunt between Ain1 and Osl1.

260 the NMDA receptor antagonist MK-801 and the GABA(A) receptor antagonist bicuculline methiodide while

261 er were also immunoreactive for GABA and the GABA-synthesizing enzyme glutamic acid decarboxylase.

262 In contrast, the GABA(A) agonist, muscimol, induced general disruptions t

263 and expression of KCC2, thereby delaying the GABA switch in pups of both sexes.

264 pression of metabolites and enzymes from the GABA-glutamate, GABA-putrescine, and the glyoxylate path

265 es insulin-like peptide transcription in the GABA receptor neurons downstream of short neuropeptide F

266 e that blockade of the alpha5 subtype of the GABA receptor (alpha5-GABA(A)Rs) leads to behavioral phe

267 teracting at the NCA site in the pore of the GABA(A) receptor at a location that is overlapping but n

268 aria and a potent orthosteric agonist of the GABA(A) receptor.

269 estigated whether a single 10 mg dose of the GABA(B) agonist baclofen impaired motor sequence learnin

270 lutamatergic and increased expression of the GABA-ergic synaptic markers, possibly via non-apoptotic

271 to the modes of action of these drugs on the GABA(A) receptor.

272 c neurotransmitter identity and suppress the GABA fate.

273 ession and silencing, we identified that the GABA(A)R subunit combination alpha3beta2gamma1 conforms

274 ibition of endogenous GHB formation with the GABA transaminase inhibitor vigabatrin also failed to in

275 ndently, of retinal environment age on their GABA(A) receptor (GABA(A)R) responses, elicited by musci

276 idal cells whereas increasing [GABA] through GABA uptake blockade shortens it.

277 s of CO(2) and likely to be mediated through GABA(A)R activity, based on in vitro recordings.

278 % of the evoked response is mediated through GABA(A)Rs which are only activated by evoked neurotransm

279 f running also induces switching from ACh to GABA expression in neurons in the caudal pedunculopontin

280 We measured both total GABA(A) receptor densities by using [(18)F]flumazenil po

281 a novel class of inhibitory neurons that use GABA and NPY signaling to regulate activity in the IC an

282 Similar to the widely used GABA receptor type A (GABA(A)) antagonist picrotoxinin,

283 Using GABA(A)R subunit expression and silencing, we identified

284 that inhibition of the insular cortex using GABA agonists impairs performance of the task.

285 vioral and neurophysiological deficits using GABA(A)R antagonists led to hypothesize an excessive act

286 MPOA neurons that express ESR1 and vesicular GABA transporter (VGAT) (MPOA(ESR1 VGAT) neurons) robust

287 o-localizations between pSTAT5 and vesicular GABA transporter or vasopressin were observed, whereas a

288 not involve presynaptic component vesicular GABA transporters.

289 ng channelrhodopsin-(ChR2)-EYFP in vesicular GABA transporter (VGAT)-expressing neurons.

290 s contrasting influences on GABA input to VP(GABA) and VP(vGluT2) neurons and these influences are af

291 ferents from other brain regions than in VTA GABA neurons.

292 However, lesion of VTA GABA neurons failed to disrupt this effect.

293 n opioid reward and relapse than MORs on VTA GABA neurons.SIGNIFICANCE STATEMENT Opioid reward has lo

294 ts revealed significantly higher GABA/Water (GABA normalized by water signal) in the left DLPFC of in

295 cally inhibits dopamine release, but whether GABA-A receptors directly modulate transmission or act i

296 key structure in the reward system, in which GABA neurotransmission is regulated by opioid neuropepti

297 GABA and the endocannabinoid system in which GABA signaling accelerates endocannabinoid degradation,

298 Structures in which GABA(A) receptors are bound by benzodiazepine-site ligan

299 ) recognizes orthosteric ligands(7,8), while GABA(B2) couples with G proteins(9-14).

300 al transmembrane proteins that interact with GABA(A)Rs and modulate their trafficking and function.